Analysis Article • Aug 07

Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by Chartwell Retirement Residences declining 3.1%. Over the past 12 months, the industry was up 8.1%. Earnings are forecast to grow by 30% annually.
Has the Canadian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 12 Sep 2026 | CA$40.1b | CA$20.4b | -CA$1,100,000,510.89 | 19.2x | -36.5x | 2x |
| Mon, 10 Aug 2026 | CA$33.3b | CA$17.6b | -CA$1,634,390,314.04 | 19x | -20.4x | 1.9x |
| Wed, 08 Jul 2026 | CA$34.5b | CA$17.3b | -CA$1,960,961,135.17 | 23.5x | -17.6x | 2x |
| Fri, 05 Jun 2026 | CA$35.5b | CA$18.7b | -CA$2,117,987,969.69 | 17.7x | -16.7x | 1.9x |
| Sun, 03 May 2026 | CA$36.7b | CA$17.4b | -CA$1,899,899,917.08 | 27.5x | -19.3x | 2.1x |
| Tue, 31 Mar 2026 | CA$29.9b | CA$17.6b | -CA$1,946,781,976.83 | 18.7x | -15.3x | 1.7x |
| Thu, 26 Feb 2026 | CA$33.6b | CA$17.6b | -CA$2,139,963,884.53 | 20.6x | -15.7x | 1.9x |
| Sat, 24 Jan 2026 | CA$34.4b | CA$17.5b | -CA$2,183,706,427.60 | 22.4x | -15.8x | 2x |
| Mon, 22 Dec 2025 | CA$36.3b | CA$19.2b | -CA$2,218,049,355.91 | 18.3x | -16.4x | 1.9x |
| Wed, 19 Nov 2025 | CA$31.0b | CA$19.3b | -CA$2,168,680,474.37 | 18.8x | -14.3x | 1.6x |
| Fri, 17 Oct 2025 | CA$38.3b | CA$19.5b | -CA$2,334,666,435.77 | 41.2x | -16.4x | 2x |
| Sun, 14 Sep 2025 | CA$33.8b | CA$19.4b | -CA$2,309,057,574.71 | 41.2x | -14.6x | 1.7x |
| Tue, 12 Aug 2025 | CA$31.7b | CA$19.7b | -CA$2,698,143,101.07 | 29x | -11.8x | 1.6x |
| Thu, 10 Jul 2025 | CA$28.4b | CA$19.5b | -CA$2,787,249,766.78 | 24.2x | -10.2x | 1.5x |
| Sat, 07 Jun 2025 | CA$27.0b | CA$19.5b | -CA$2,818,943,002.62 | 22.8x | -9.6x | 1.4x |
| Mon, 05 May 2025 | CA$27.9b | CA$19.5b | -CA$2,751,222,867.36 | 26x | -10.1x | 1.4x |
| Wed, 02 Apr 2025 | CA$26.0b | CA$20.0b | -CA$2,842,550,155.53 | 19.4x | -9.1x | 1.3x |
| Fri, 28 Feb 2025 | CA$27.8b | CA$19.9b | -CA$2,506,042,121.43 | 23.1x | -11.1x | 1.4x |
| Sun, 26 Jan 2025 | CA$28.3b | CA$19.8b | -CA$2,714,894,200.53 | 33.5x | -10.4x | 1.4x |
| Tue, 24 Dec 2024 | CA$28.7b | CA$19.8b | -CA$2,739,171,100.10 | 25x | -10.5x | 1.4x |
| Thu, 21 Nov 2024 | CA$30.0b | CA$19.9b | -CA$2,939,873,055.84 | 17.4x | -10.2x | 1.5x |
| Sat, 19 Oct 2024 | CA$34.1b | CA$19.4b | -CA$2,973,484,725.38 | 20.6x | -11.5x | 1.8x |
| Mon, 16 Sep 2024 | CA$32.6b | CA$19.3b | -CA$2,982,041,003.58 | 21.4x | -10.9x | 1.7x |
| Wed, 14 Aug 2024 | CA$32.3b | CA$19.2b | -CA$3,142,515,822.58 | 23.3x | -10.3x | 1.7x |
| Fri, 12 Jul 2024 | CA$32.0b | CA$19.1b | -CA$3,643,813,555.42 | 20x | -8.8x | 1.7x |
| Sun, 09 Jun 2024 | CA$33.5b | CA$19.4b | -CA$3,302,737,566.33 | 17.7x | -10.1x | 1.7x |
| Tue, 07 May 2024 | CA$36.2b | CA$19.2b | -CA$3,994,047,069.56 | 16.9x | -9.1x | 1.9x |
| Thu, 04 Apr 2024 | CA$32.6b | CA$17.9b | -CA$4,056,486,376.96 | 12.2x | -8x | 1.8x |
| Sat, 02 Mar 2024 | CA$33.0b | CA$19.3b | -CA$5,027,415,033.30 | 13.2x | -6.6x | 1.7x |
| Mon, 29 Jan 2024 | CA$37.7b | CA$20.1b | -CA$7,670,250,299.00 | 11.3x | -4.9x | 1.9x |
| Wed, 27 Dec 2023 | CA$32.2b | CA$19.9b | -CA$7,642,151,504.00 | 13.5x | -4.2x | 1.6x |
| Fri, 24 Nov 2023 | CA$33.3b | CA$20.2b | -CA$7,873,898,101.00 | 16.1x | -4.2x | 1.6x |
| Sun, 22 Oct 2023 | CA$32.0b | CA$20.0b | -CA$8,402,080,042.00 | 17.8x | -3.8x | 1.6x |
| Tue, 19 Sep 2023 | CA$37.7b | CA$20.5b | -CA$8,932,134,692.00 | 17.4x | -4.2x | 1.8x |
-4.2x
Which industries have driven the changes within the Canadian Healthcare sector?
| CA Market | -1.85% | |
| Healthcare | -2.25% | |
| Life Sciences | -0.62% | |
| Pharma | -1.05% | |
| Healthcare Services | -3.16% | |
| Biotech | -3.63% | |
| Healthtech | -6.77% | |
| Medical Equipment | -8.75% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| APTX Apotex Health | CA$35.55 | 5.7% +CA$438.7m | n/a | PS2.5x | |
| IAN iAnthus Capital Holdings | CA$0.01 | 100.0% +CA$34.9m | 0% | PS0.4x | |
| MSCL Satellos Bioscience | CA$13.20 | 6.0% +CA$15.9m | 64.2% | PB3.4x | |
| SHRX Sharp Therapeutics | CA$1.37 | 50.5% +CA$14.5m | 174.0% | PE-6x | |
| NTLX Neurothera Labs | CA$4.39 | 30.7% +CA$14.1m | n/a | PS63.9x |